PULMONX CORPORATION (LUNG) Operating Margin
- Operating margin · 12 months: Value -52.96%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | -52.96% | Operating income / revenue. Period ending 2026-06-30. $-46.31M ÷ $87.44M × 100 ≈ -52.96% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -46.31M USD | Operating Income (Loss) |
| Revenue | 87.44M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 20.06M USD | Cost of Goods and Services Sold |
| Research and development | 19.36M USD | Research and Development Expense |
| Selling, general and administration | 94.33M USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $-46.31M | $87.44M | $20.06M | $19.36M | $94.33M | -52.96% |
| 2026-03-31 | $-52.06M | $88.55M | $21.70M | $19.63M | $99.26M | -58.79% |
| 2025-12-31 | $-53.66M | $90.50M | $23.36M | $19.49M | $101.31M | -59.30% |
| 2025-09-30 | $-57.18M | $91.66M | $24.48M | $18.91M | $105.46M | -62.38% |
| 2025-06-30 | $-56.91M | $90.55M | $24.39M | $17.81M | $105.27M | -62.85% |
| 2025-03-31 | $-57.73M | $87.47M | $23.21M | $18.12M | $103.88M | -66.00% |
| 2024-12-31 | $-57.70M | $83.79M | $21.79M | $17.57M | $102.14M | -68.87% |
| 2024-09-30 | $-58.21M | $79.30M | $20.49M | $17.46M | $99.55M | -73.40% |
| 2024-06-30 | $-59.25M | $76.58M | $19.77M | $17.94M | $98.13M | -77.37% |
| 2024-03-31 | $-60.07M | $72.99M | $18.75M | $18.04M | $96.28M | -82.30% |
| 2023-12-31 | $-61.94M | $68.67M | $17.92M | $18.08M | $94.61M | -90.19% |
| 2023-09-30 | $-62.64M | $64.82M | $17.29M | $18.09M | $92.09M | -96.64% |
| 2023-06-30 | $-61.40M | $60.66M | $16.00M | $18.23M | $87.82M | -101.22% |
| 2023-03-31 | $-59.37M | $57.41M | $15.07M | $16.12M | $85.60M | -103.41% |
| 2022-12-31 | $-58.64M | $53.66M | $13.80M | $15.40M | $83.11M | -109.27% |
| 2022-09-30 | $-56.38M | $51.95M | $13.01M | $15.20M | $80.11M | -108.53% |
| 2022-06-30 | $-52.21M | $51.70M | $13.19M | $13.65M | $77.08M | -100.97% |
| 2022-03-31 | $-50.48M | $49.96M | $12.83M | $13.56M | $74.05M | -101.04% |
| 2021-12-31 | $-47.30M | $48.42M | $12.79M | $13.06M | $69.87M | -97.70% |
| 2021-09-30 | $-44.29M | $44.54M | $12.08M | $11.83M | $64.92M | -99.45% |
| 2021-06-30 | $-38.83M | $41.89M | $11.71M | $11.01M | $58.00M | -92.69% |
| 2021-03-31 | $-38.26M | $33.36M | $11.20M | $8.93M | $51.49M | -114.68% |
| 2020-12-31 | $-32.33M | $32.73M | $11.53M | $7.46M | $46.07M | -98.77% |
| 2020-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | $31.74M | (m) | (m) | (m) | (m) |
| 2020-03-31 | (m) | $35.44M | (m) | (m) | (m) | (m) |
| 2019-12-31 | $-17.84M | $32.59M | $10.18M | $6.05M | $34.20M | -54.73% |
| 2019-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | $-15.05M | $20.00M | $7.72M | $6.99M | $20.35M | -75.24% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |